Skip to main content

Advertisement

Log in

Leukemic Transformation of Severe Aplastic Anemia Following Matched Allogenic Stem Cell Transplantation, Transplanted Again in CR 1

  • Case Report
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

Aplastic anemia (AA) is a life-threatening bone marrow failure disorder, if untreated, is associated with very high mortality. Allogenic bone marrow transplantation (BMT) is the standard of care for severe aplastic anemia (SAA) patients those who are younger than 40 years of age. The development of secondary malignancies in post-BMT setting for AA is a rare, however, well documented phenomenon. Among the secondary malignancies, development of acute myeloid leukemia is even rarer entity. Here we report a case of acute myeloid leukemia following human leucocyte antigen (HLA) matched sibling peripheral blood stem cell transplant (PBSCT) in a case of SAA. The patient achieved complete remission (CR) following chemotherapy and in CR1, a second HLA matched PBSCT from a different donor was offered. The patient is presently in remission at day +180 post-PBSCT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Deeg HJ, Socié G, Schoch G et al (1996) Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 87:386–392

    CAS  PubMed  Google Scholar 

  2. Otero L, de Souza DC, de Cássia Tavares R et al (2012) Monosomy 7 in donor cell-derived leukemia after bone marrow transplantation for severe aplastic anemia: report of a new case and review of the literature. Genet Mol Biol 35:734–736

    Article  PubMed  PubMed Central  Google Scholar 

  3. Lawler M, Locasciulli A, Longoni D et al (2002) Leukemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anemia. Bone Marrow Transpl 29:453–456

    Article  CAS  Google Scholar 

  4. Camitta BM, Rappeport JM, Parkman R et al (1975) Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood 45:355–363

    CAS  PubMed  Google Scholar 

  5. Marsh JC, Ball SE, Cavenagh J et al (2009) British Committee for Standards in Haematology. Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol 147:43–70

    Article  CAS  PubMed  Google Scholar 

  6. Kojima S, Ohara A, Tsuchida M, Japan Childhood Aplastic Anemia Study Group et al (2002) Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood 100:786–790

    Article  CAS  PubMed  Google Scholar 

  7. Maciejewski JP, Risitano A, Sloand EM et al (2002) Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia. Blood 99:3129–3135

    Article  CAS  PubMed  Google Scholar 

  8. Keung YK, Pettenati MJ, Cruz JM et al (2001) Bone marrow cytogenetic abnormalities of aplastic anemia. Am J Hematol 66:167–171

    Article  CAS  PubMed  Google Scholar 

  9. Varma N, Varma S, Movafagh A et al (1995) Unusual clonal cytogenetic abnormalities in aplastic anemia. Am J Hematol 49:256–257

    Article  CAS  PubMed  Google Scholar 

  10. Klingemann HG, Storb R, Sanders J et al (1986) Acute lymphoblastic leukaemia after bone marrow transplantation for aplastic anaemia. Br J Haematol 63:47–50

    Article  CAS  PubMed  Google Scholar 

  11. Haltrich I, Müller J, Szabó J et al (2003) Donor-cell myelodysplastic syndrome developing 13 years after marrow grafting for aplastic anemia. Cancer Genet Cytogenet 142:124–128

    Article  PubMed  Google Scholar 

  12. Hashino S, Fujisawa F, Kondo T et al (2006) Donor-type myelodysplastic syndrome with t(2;3) and monosomy 7 after allogeneic peripheral blood stem cell transplantation and liver transplantation in a patient with severe-type aplastic anemia. Int J Hematol 84:363–366

    Article  PubMed  Google Scholar 

  13. Hughes RT, Milligan DW, Smith GM et al (1988) A second bone marrow transplant for acute myeloid leukaemia after transplantation for aplastic anaemia. Br J Haematol 68:391

    Article  CAS  PubMed  Google Scholar 

  14. Sevilla J, Querol S, Molines A et al (2006) Transient donor cell-derived myelodysplastic syndrome with monosomy 7 after unrelated cord blood transplantation. Eur J Haematol 77:259–263

    Article  PubMed  Google Scholar 

  15. Hamaki T, Kajiwara K, Kami M et al (2008) Donor cell-derived acute monoblastic leukemia involving MLL gene translocation in an adult patient who received umbilical cord blood transplantation. Bone Marrow Transplant 41:91–92

    Article  CAS  PubMed  Google Scholar 

  16. Browne PV, Lawler M, Humphries P et al (1991) Donor-cell leukemia after bone marrow transplantation for severe aplastic anemia. N Engl J Med 325:710–713

    Article  CAS  PubMed  Google Scholar 

  17. Tallman MS, Rowlings PA, Milone G et al (2000) Effect of post-remission chemotherapy prior to HLA-identicalsibling transplantation for acute myelogenous leukemia in first complete remission. Blood 96:1254–1258

    CAS  PubMed  Google Scholar 

  18. Rowe JM (2002) Therapy of secondary leukemia. Leukemia 16:748–750

    Article  CAS  PubMed  Google Scholar 

  19. Pagano L, Pulsoni A, Vignetti M et al (2005) Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials. Ann Oncol 16:228–233

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mukul Aggarwal.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Manivannan, P., Purohit, A., Somasundaram, V. et al. Leukemic Transformation of Severe Aplastic Anemia Following Matched Allogenic Stem Cell Transplantation, Transplanted Again in CR 1. Indian J Hematol Blood Transfus 32 (Suppl 1), 223–227 (2016). https://doi.org/10.1007/s12288-014-0484-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-014-0484-z

Keywords

Navigation